The global burden of kidney disease and the sustainable development goals.
Valerie A Luyckx, Marcello Tonelli, John W Stanifer
https://pubmed.ncbi.nlm.nih.gov/29904224Actively Recruiting
Age: 2Years +
All Genders
ID05036850
China Kidney Patient Trials Network
Led by George (Beijing) Clinical Research Co. Ltd. · Updated on 2023-03-06
1200
Participants Needed
1
Research Sites
232 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective multi-center observational study involving patients diagnosed with kidney disease in China. This study aims to collect detailed information from both new and existing kidney disease patients to better understand the condition over time. Participants include both newly diagnosed and existing patients from various centers who regularly visit their doctors. The study does not involve any treatment but observes patients' health status, focusing on measurements such as estimated Glomerular Filtration Rate (eGFR) and albuminuria. Participants will have their kidney function measured every six months for up to five years. The study involves regular check-ups, data collection, and monitoring to track kidney disease progression. The research team will analyze these measurements to better understand kidney disease outcomes and potentially improve future care.
CONDITIONS
Brief Title
China Kidney Patient Trials Network
Who Can Participate
Age: 2Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Documented diagnosis of primary kidney disease
- Regular visits (at least every 6 months) with a physician at a participating center
- Estimated Glomerular Filtration Rate (eGFR) above 15 ml/min/1.73 m2
- Age 2 years or older
- Willing and able to sign informed consent
- Willing to be approached about participation in interventional research studies
You will not qualify if you...
- Life expectancy of less than 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 5 years
Participants are monitored with regular assessments of kidney function and albuminuria to track disease progression.
Visits every 6 months
Trial Site Locations
Total: 1 location
1
George Clinical (Beijing)
Beijing, Beijing Municipality, China, 100125
Actively Recruiting
Loading map...
Research Team
F
FanHan Hsu
D
Dan Yuan
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.
Marcello Tonelli, Paul Muntner, Anita Lloyd...
https://pubmed.ncbi.nlm.nih.gov/22717317Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
Alan S Go, Glenn M Chertow, Dongjie Fan...
https://pubmed.ncbi.nlm.nih.gov/15385656The incidence of primary glomerulonephritis worldwide: a systematic review of the literature.
Anita McGrogan, Casper F M Franssen, Corinne S de Vries
https://pubmed.ncbi.nlm.nih.gov/21068142The number, quality, and coverage of randomized controlled trials in nephrology.
Giovanni F M Strippoli, Jonathan C Craig, Francesco P Schena
https://pubmed.ncbi.nlm.nih.gov/14747388Action plan for optimizing the design of clinical trials in chronic kidney disease.
Vlado Perkovic, Jonathan C Craig, Worawon Chailimpamontree...
https://pubmed.ncbi.nlm.nih.gov/30675428Renal trials in diabetes need a platform: time for a global approach?
Dick de Zeeuw, Hiddo J L Heerspink, Meg Jardine...
https://pubmed.ncbi.nlm.nih.gov/28797748